Klöckner Pentaplast’s pharma and medical device films division (kp PMD) has introduced new ultra-high barrier PVdC film, Pentapharm alfoil ET SG.
Image: The new alfoil ET SG films expand Klöckner’s portfolio of pharmaceutical blister films for high barrier market. Photo: courtesy of adamr / FreeDigitalPhotos.net.
The new Pentapharm alfoil ET SG films are said to expand the firm’s portfolio of pharmaceutical blister films for high barrier market.
The alfoil ET SG films can be used in a range of applications, including ethical, OTC, generics, veterinary and nutraceutical.
Klöckner has provided triplex structure with super glide (SG) finish to enable high line speed with low friction. It also features smooth surface and improved product feeding.
With advanced moisture and oxygen barrier properties, the new films will help reduce stickiness, as well as improve barrier performance and package integrity.
With production in Switzerland, the alfoil ET SG film is available across the globe.
Klöckner Pentaplast sales senior vice president Michael Vollgold said: “alfoil ET SG delivers outstanding value to performance ratio with a specially formulated color package to guarantee a consistent visual appearance while protecting your brand.
“The unique benefit of the SG finish will help reduce stickiness while improving package integrity. This leads to higher line productivity and yields for our customers.”
Recently, kp PMD has announced that it will expand its global production capacity in North America.
The company is set to invest $25m in the next five years in technology and processes to deliver advanced, functional and safe products to the customers.
In February this year, Klöckner’s division announced a €5m investment in its Bern facility located in Switzerland.
The investment is being used to expand the capacity at Swiss facility by 30%, enabling to meet the market requirements in EMEA and support expansion into Asia.
Established in 1965, Klöckner Pentaplast offers rigid and flexible packaging, printing and specialty solutions for the customers in the pharmaceutical, medical device, food, beverage and card markets.
The company has operations in 18 countries, and employs more than 6,300 people to serve customers across the globe. It has 61 locations, including 32 production sites.